{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:51:36Z","timestamp":1791474696456,"version":"4.3.4"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.bioorg.2022.106162","type":"journal-article","created":{"date-parts":[[2022,9,24]],"date-time":"2022-09-24T20:15:26Z","timestamp":1664050526000},"page":"106162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Discovery of novel 1,2,4-triazole derivatives as xanthine oxidoreductase inhibitors with hypouricemic effects"],"prefix":"10.1016","volume":"129","author":[{"given":"Yajun","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanzeng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanglei","family":"Nan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianxin","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuechen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinying","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5276-3761","authenticated-orcid":false,"given":"Zhiyan","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bioorg.2022.106162_b0005","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/2040622315618393","article-title":"Gout: optimizing treatment to achieve a disease cure","volume":"7","author":"Bernal","year":"2016","journal-title":"Ther Adv Chronic Dis"},{"issue":"3","key":"10.1016\/j.bioorg.2022.106162_b0010","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/14728214.2018.1527899","article-title":"Expert opinion on emerging urate-lowering therapies","volume":"23","author":"Stamp","year":"2018","journal-title":"Expert Opin Emerg Drugs"},{"issue":"7","key":"10.1016\/j.bioorg.2022.106162_b0015","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/cmdc.201900034","article-title":"Inhibitors of xanthine oxidase: Scaffold diversity and structure-based drug design","volume":"14","author":"Luna","year":"2019","journal-title":"ChemMedChem"},{"issue":"4","key":"10.1016\/j.bioorg.2022.106162_b0020","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/med.21457","article-title":"Toward an understanding of structural insights of xanthine and aldehyde oxidases: An overview of their inhibitors and role in various diseases","volume":"38","author":"Kumar","year":"2018","journal-title":"Med Res Rev"},{"issue":"8","key":"10.1016\/j.bioorg.2022.106162_b0025","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1517\/13543784.2015.1051617","article-title":"Investigational drugs for hyperuricemia","volume":"24","author":"Shahid","year":"2015","journal-title":"Expert Opin Investig Drugs"},{"issue":"5","key":"10.1016\/j.bioorg.2022.106162_b0030","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1080\/13543784.2018.1471133","article-title":"Investigational drugs for hyperuricemia, an update on recent developments","volume":"27","author":"Pascart","year":"2018","journal-title":"Expert Opin Investig Drugs"},{"issue":"1","key":"10.1016\/j.bioorg.2022.106162_b0035","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1124\/jpet.110.174540","article-title":"FYX-051: a novel and potent hybrid-type inhibitor of xanthine oxidoreductase","volume":"336","author":"Matsumoto","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bioorg.2022.106162_b0040","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.ejmech.2018.01.060","article-title":"Design, synthesis and biological evaluation of 1-hydroxy-2-phenyl-4-pyridyl-1H-imidazole derivatives as xanthine oxidase inhibitors","volume":"146","author":"Zhang","year":"2018","journal-title":"Eur J Med Chem"},{"issue":"9","key":"10.1016\/j.bioorg.2022.106162_b0045","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1021\/jm00219a016","article-title":"2-pyridylimidazoles as inhibitors of xanthine oxidase","volume":"20","author":"Baldwin","year":"1977","journal-title":"J Med Chem"},{"issue":"16","key":"10.1016\/j.bioorg.2022.106162_b0050","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1016\/j.bmcl.2017.06.059","article-title":"Synthesis and evaluation of 1-phenyl-1H-1,2,3-triazole-4-carboxylic acid derivatives as xanthine oxidase inhibitors","volume":"27","author":"Zhang","year":"2017","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bioorg.2022.106162_b0055","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ejmech.2017.09.051","article-title":"Design, synthesis and biological evaluation of N-(4-alkoxy-3-cyanophenyl)isonicotinamide\/ nicotinamide derivatives as novel xanthine oxidase inhibitors","volume":"141","author":"Zhang","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bioorg.2022.106162_b0060","doi-asserted-by":"crossref","first-page":"111717","DOI":"10.1016\/j.ejmech.2019.111717","article-title":"Design, synthesis and biological evaluation of N-(3-(1H-tetrazol-1-yl)phenyl)isonicotinamide derivatives as novel xanthine oxidase inhibitors","volume":"183","author":"Zhang","year":"2019","journal-title":"Eur J Med Chem"},{"issue":"1","key":"10.1016\/j.bioorg.2022.106162_b0065","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.bmcl.2008.10.122","article-title":"Design, synthesis, and pharmacological and pharmacokinetic evaluation of 3-phenyl-5-pyridyl-1,2,4-triazole derivatives as xanthine oxidoreductase inhibitors","volume":"19","author":"Sato","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"issue":"6","key":"10.1016\/j.bioorg.2022.106162_b0070","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1016\/j.bmc.2011.01.058","article-title":"A rational approach for the design and synthesis of 1-acetyl-3,5-diaryl-4,5-dihydro(1H)pyrazoles as a new class of potential non-purine xanthine oxidase inhibitors","volume":"19","author":"Nepali","year":"2011","journal-title":"Bioorg Med Chem"},{"issue":"7","key":"10.1016\/j.bioorg.2022.106162_b0075","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/ardp.201400031","article-title":"4,6-Diaryl\/heteroarylpyrimidin-2(1H)-ones as a new class of xanthine oxidase inhibitors","volume":"347","author":"Shukla","year":"2014","journal-title":"Arch Pharm (Weinheim)"},{"issue":"18","key":"10.1016\/j.bioorg.2022.106162_b0080","doi-asserted-by":"crossref","first-page":"5569","DOI":"10.1016\/j.bmc.2011.07.039","article-title":"N-(1,3-Diaryl-3-oxopropyl)amides as a new template for xanthine oxidase inhibitors","volume":"19","author":"Nepali","year":"2011","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bioorg.2022.106162_b0085","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cbi.2015.01.022","article-title":"Xanthine oxidase inhibitory properties and anti-inflammatory activity of 2-amino-5-alkylidene-thiazol-4-ones","volume":"229","author":"Smelcerovic","year":"2015","journal-title":"Chem Biol Interact"},{"issue":"7","key":"10.1016\/j.bioorg.2022.106162_b0090","doi-asserted-by":"crossref","first-page":"886","DOI":"10.3109\/09637486.2014.931362","article-title":"Flavonols and flavan-3-ols as modulators of xanthine oxidase and manganese superoxide dismutase activity","volume":"65","author":"Di Majo","year":"2014","journal-title":"Int J Food Sci Nutr"},{"key":"10.1016\/j.bioorg.2022.106162_b0095","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.bioorg.2014.08.007","article-title":"Synthesis and xanthine oxidase inhibitory activity of 5,6-dihydropyrazolo\/pyrazolo[1,5-c]quinazoline derivatives","volume":"57","author":"Kumar","year":"2014","journal-title":"Bioorg Chem"},{"issue":"3","key":"10.1016\/j.bioorg.2022.106162_b0100","first-page":"1848","article-title":"An extremely potent inhibitor of xanthine oxidoreductase","volume":"278","author":"Okamoto","year":"2003","journal-title":"Crystal structure of the enzyme-inhibitor complex and mechanism of inhibition, J Biol Chem"},{"issue":"21","key":"10.1016\/j.bioorg.2022.106162_b0105","doi-asserted-by":"crossref","first-page":"7931","DOI":"10.1073\/pnas.0400973101","article-title":"The crystal structure of xanthine oxidoreductase during catalysis: implications for reaction mechanism and enzyme inhibition","volume":"101","author":"Okamoto","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"19","key":"10.1016\/j.bioorg.2022.106162_b0110","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1016\/j.tetlet.2005.02.167","article-title":"A base-catalyzed, direct synthesis of 3,5-disubstituted 1,2,4-triazoles from nitriles and hydrazides","volume":"46","author":"Yeung","year":"2005","journal-title":"Tetrahedron Lett"},{"issue":"5","key":"10.1016\/j.bioorg.2022.106162_b0115","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/cmdc.201900682","article-title":"Morpholine as a scaffold in medicinal chemistry: An update on synthetic strategies","volume":"15","author":"Tzara","year":"2020","journal-title":"ChemMedChem"},{"issue":"46","key":"10.1016\/j.bioorg.2022.106162_b0120","doi-asserted-by":"crossref","first-page":"27752","DOI":"10.1039\/D0RA03143G","article-title":"Identification of xanthine oxidase inhibitors through hierarchical virtual screening","volume":"10","author":"Yang","year":"2020","journal-title":"RSC Adv"},{"key":"10.1016\/j.bioorg.2022.106162_b0125","first-page":"1471","article-title":"Establishment of a screening system for xanthine oxidase (XOD) inhibitors","volume":"35","author":"Yan","year":"2019","journal-title":"Chin Pharmaco Bull"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206822005685?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206822005685?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:40:16Z","timestamp":1758616816000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206822005685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":25,"alternative-id":["S0045206822005685"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2022.106162","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of novel 1,2,4-triazole derivatives as xanthine oxidoreductase inhibitors with hypouricemic effects","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2022.106162","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106162"}}